The influence of cross-sectoral treatment models on patients with mental disorders in Germany: study protocol of a nationwide long-term evaluation study (EVA64).

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: BioMed Central Country of Publication: England NLM ID: 100968559 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-244X (Electronic) Linking ISSN: 1471244X NLM ISO Abbreviation: BMC Psychiatry Subsets: MEDLINE
    • Publication Information:
      Original Publication: London : BioMed Central, [2001-
    • Subject Terms:
      Intersectoral Collaboration*; Health Services Research/*methods ; Mental Disorders/*therapy ; Mental Health Services/*economics ; Patient-Centered Care/*methods; Adult ; Budgets ; Cohort Studies ; Comorbidity ; Cost-Benefit Analysis ; Databases, Factual ; Evaluation Studies as Topic ; Female ; Germany ; Guideline Adherence ; Hospitalization ; Humans ; Insurance, Health ; Longitudinal Studies ; Male ; Middle Aged ; Patient-Centered Care/economics ; Research Design
    • Abstract:
      Background: Close, continuous and efficient collaboration between different professions and sectors of care is necessary to provide patient-centered care for individuals with mental disorders. The lack of structured collaboration between in- and outpatient care constitutes a limitation of the German health care system. Since 2012, a new law in Germany (§64b Social code book (SGB) V) has enabled the establishment of cross-sectoral and patient-centered treatment models in psychiatry. Such model projects follow a capitation budget, i.e. a total per patient budget of inpatient and outpatient care in psychiatric clinics. Providers are able to choose the treatment form and adapt the treatment to the needs of the patients. The present study (EVA64) will investigate the effectiveness, costs and efficiency of almost all model projects established in Germany between 2013 and 2016.
      Methods/design: A health insurance data-based controlled cohort study is used. Data from up to 89 statutory health insurance (SHI) funds, i.e. 79% of all SHI funds in Germany (May 2017), on inpatient and outpatient care, pharmaceutical and non-pharmaceutical treatments and sick leave for a period of 7 years will be analyzed. All patients insured by any of the participating SHI funds and treated in one of the model hospitals for any of 16 pre-defined mental disorders will be compared with patients in routine care. Sick leave (primary outcome), utilization of inpatient care (primary outcome), utilization of outpatient care, continuity of contacts in (psychiatric) care, physician and hospital hopping, re-admission rate, comorbidity, mortality, disease progression, and guideline adherence will be analyzed. Cost and effectivity of model and routine care will be estimated using cost-effectiveness analyses. Up to 10 control hospitals for each of the 18 model hospitals will be selected according to a pre-defined algorithm.
      Discussion: The evaluation of complex interventions is an important main task of health services research and constitutes the basis of evidence-guided advancement in health care. The study will yield important new evidence to guide the future provision of routine care for mentally ill patients in Germany and possibly beyond.
      Trial Registration: This study was registered in the database "Health Services Research Germany" (trial number: VVfD_EVA64_15_003713 ).
    • References:
      Nervenarzt. 2012 May;83(5):595-603. (PMID: 22532326)
      Dtsch Arztebl Int. 2009 Oct;106(41):664-8. (PMID: 19946431)
      Gesundheitswesen. 2019 Jan;81(1):63-71. (PMID: 27846670)
      Fortschr Neurol Psychiatr. 2013 Nov;81(11):628-38. (PMID: 24194056)
      Med Care. 2005 Nov;43(11):1130-9. (PMID: 16224307)
      Gesundheitswesen. 2015 Sep;77(8-9):570-9. (PMID: 26270043)
      Int J Qual Health Care. 2006 Sep;18 Suppl 1:31-8. (PMID: 16954514)
      Health Care Financ Rev. 1997 Spring;18(3):73-93. (PMID: 10170355)
      J Behav Health Serv Res. 1999 Nov;26(4):442-50. (PMID: 10565104)
      Psychiatr Prax. 2013 Nov;40(8):430-8. (PMID: 23695948)
      Gesundheitswesen. 2015 Feb;77(2):120-6. (PMID: 25622207)
      Plast Reconstr Surg. 2010 Aug;126(2):619-625. (PMID: 20679844)
      Dtsch Arztebl Int. 2013 Feb;110(6):92-100. (PMID: 23451001)
      Psychiatr Prax. 2010 Jan;37(1):34-42. (PMID: 20072988)
      Compr Psychiatry. 2014 Apr;55(3):426-30. (PMID: 24405773)
      Adm Policy Ment Health. 2005 Mar;32(4):321-40. (PMID: 15844852)
      Nervenarzt. 2013 Mar;84(3):350-65. (PMID: 23494246)
      Psychiatr Prax. 2013 Nov;40(8):414-24. (PMID: 23681791)
      Int J Integr Care. 2016 Dec 31;16(4):17. (PMID: 28413369)
      Gesundheitswesen. 2016 Sep;78(S 01):e161. (PMID: 27428525)
      J Biopharm Stat. 2011 Nov;21(6):1052-62. (PMID: 22023675)
      Fortschr Neurol Psychiatr. 2013 Nov;81(11):614-27. (PMID: 24194055)
      Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2015 Sep;58(9):996-1004. (PMID: 26133162)
    • Contributed Indexing:
      Keywords: Claims data; Effectiveness and cost-effectiveness; Health care system; Health services research; Inpatient and outpatient treatment; Psychiatric health care; Routine data; Setting approach; Statutory health insurance
    • Publication Date:
      Date Created: 20180520 Date Completed: 20190305 Latest Revision: 20240325
    • Publication Date:
      20240325
    • Accession Number:
      PMC5960179
    • Accession Number:
      10.1186/s12888-018-1721-z
    • Accession Number:
      29776348